FDA Narrows COVID-19 Vaccine Approvals to Those at High Risk
Favicon 
www.newsmax.com

FDA Narrows COVID-19 Vaccine Approvals to Those at High Risk

The Food and Drug Administration on Wednesday approved updated COVID-19 vaccines from Pfizer and Moderna for the upcoming respiratory virus season, but limited eligibility to seniors and people at heightened risk of severe illness.